The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
European spending on outsourced logistics services in the pharma
industry is likely to exceed $2bn (€1.5bn) in 2011 as opportunities
arise for 3PL providers who want to grab a chunk of this burgeoning
market, according to a new report.
The burgeoning Japanese pharmaceutical market is set to boost the
third party logistics (3PL) sector as drug makers are expected to
increase their reliance on outsourcing for this type of services in
the future, a new report said.